In a study of exosomal miRNA, elevated serum exosomal levels of miR-19b-3p and miR-106a-5p were identified in gastric cancer patients, and their combined evaluation resulted in substantial improvements in gastric cancer diagnosis, superior to the clinically used serum biomarkers AFP and CA19-9 [61]. This evidence concerns the gene AFP and gastric cancer.